Robert Klitzman, MD, professor of psychiatry, addresses the ethical and health concerns that must be considered in tackling the obesity epidemic and broader public health challenges.
A Columbia study shows a simple smell test and memory exam can predict cognitive decline as accurately as costly brain imaging, offering a more affordable and accessible way to assess dementia.
Dr. Efrat Aharonovich: Our study shows the validity of two scales for assessing how cognitive impairments are associated with many substance disorders including alcohol, cannabis, and cocaine.
New research finds that cognitive impairments are not just a problem for substance use disorder patients, but occur more broadly among substance users in the general population.
Recently published findings showed a significant increase in marijuana use among adults aged 26 and older in states that passed loosely regulated medical marijuana laws (MMLs).
The rule has to stay, said Dr. Paul Appelbaum, to protect people "who are the subject of our statements ... who might be harmed by our blind speculation."
"The whole issue of these barriers to utilization is shameful, and it's embarrassing to the field and the psychiatric profession," said Dr. Jeffrey Lieberman.
“You want to have the right information,” says Dr. Robert Klitzman, "...the soap opera could have mentioned the company’s drug as an option alongside other treatments."
The Goldwater Rule protects “the integrity of our profession from members who are willing to draw judgments on the basis on information that’s incomplete,” said Dr. Paul Appelbaum.
Suicide has proven to be a "stubbornly difficult threat to health," writes Dr. Mark Olfson. "Despite prevention efforts, the suicide rate in the United States has increased over the past decade.”